Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $57.02 and traded as low as $55.21. Utah Medical Products shares last traded at $55.55, with a volume of 14,575 shares trading hands.
Utah Medical Products Price Performance
The stock has a 50 day simple moving average of $55.64 and a 200-day simple moving average of $57.02. The firm has a market cap of $183.43 million, a PE ratio of 14.70 and a beta of 0.28.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share (EPS) for the quarter. The business had revenue of $9.71 million during the quarter. Utah Medical Products had a return on equity of 10.74% and a net margin of 33.00%.
Utah Medical Products Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, July 3rd. Stockholders of record on Monday, June 16th were paid a $0.305 dividend. This represents a $1.22 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend was Monday, June 16th. Utah Medical Products's dividend payout ratio is currently 32.28%.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. Tower Research Capital LLC TRC boosted its stake in shares of Utah Medical Products by 172.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock worth $32,000 after acquiring an additional 328 shares during the period. Wells Fargo & Company MN boosted its stake in shares of Utah Medical Products by 24.9% in the fourth quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock worth $118,000 after acquiring an additional 384 shares during the period. Bessemer Group Inc. bought a new position in Utah Medical Products during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC boosted its stake in Utah Medical Products by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock valued at $56,000 after buying an additional 500 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in Utah Medical Products by 156.9% during the first quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock valued at $50,000 after buying an additional 546 shares during the last quarter. Hedge funds and other institutional investors own 69.60% of the company's stock.
About Utah Medical Products
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Articles
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
